Intended Use
This kit is intended for the in vitro qualitative detection of clostridium difficile toxin A gene and toxin B gene in stool samples from patients with suspected clostridium difficile infection.
Epidemiology
Clostridium difficile (CD), a gram-positive anaerobic sporogenic Clostridium difficile, is one of the main pathogens causing nosocomial intestinal infections. Clinically, about 15%~25% of antimicrobial-related diarrhea, 50%~75% of antimicrobial-related colitis and 95%~100% of pseudomembranous enteritis are caused by Clostridium difficile infection (CDI). Clostridium difficile is a conditional pathogen, including toxigenic strains and non-toxigenic strains.